Semaglutide

Enroll Now

Type of Study:

Cardiovascular

Title of Study:

Semaglutide Cardiovascular Outcomes Trial in Patients With Type 2 Diabetes

Short Title:

NN4473

Study Length: 3.5 – 5 years

Target Age/Sex: over 50 years of age, Male and Female

Benefits:

Participants will receive at no cost: study product, study materials and study-specific procedures

Link: ClinicalTrials.gov

Live better, healthier, smarter

Schedule an Appointment